Canada Pension Plan Investment Board’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
JT
CAM
Canada Pension Plan Investment Board's LGND Position: Q2 2026 in Review
Canada Pension Plan Investment Board opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 700 shares worth $221K. The stake represents ﹤0.01% of the portfolio and ranks #1574 among its holdings. This is a return to the name: Canada Pension Plan Investment Board previously reported a position in LGND as recently as Q4 2025.
Canada Pension Plan Investment Board first reported a position in LGND in Q1 2014 and has held it in 17 quarters since. The position peaked at $12M in Q4 2018. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- Canada Pension Plan Investment Board held 700 shares of Ligand Pharmaceuticals worth $221K as of Q2 2026.
- Ligand Pharmaceuticals was a new Canada Pension Plan Investment Board position in Q2 2026.
- Ligand Pharmaceuticals made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1574 holding.
- Canada Pension Plan Investment Board first reported a position in Ligand Pharmaceuticals in Q1 2014 and has held it in 17 quarters since.
- Canada Pension Plan Investment Board's Ligand Pharmaceuticals position peaked at $12M in Q4 2018.
- 416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.